Our previous study showed that intraperitoneal injection of α-galactosylceramide (α-GalCer) has the ability to activate lung iNKT cells, but α-GalCer-activated iNKT cells do not result in airway inflammation in wild-type (WT) mice. Many studies showed that iNKT cells had the capacity to induce Treg cells, which gave rise to peripheral tolerance. Therefore, we examined the influence of intraperitoneal administration of α-GalCer on the expansion and suppressive activity of lung Treg cells using iNKT cell-knockout mice and co-culture experiments in vitro. We also compared airway inflammation and airway hyperresponsiveness (AHR) after α-GalCer administration in specific anti-CD25 mAb-treated mice. Our data showed that intraperitoneal injec- 
T-cell subset, bridging innate and adaptive immune responses. [5] [6] [7] Recently, iNKT cells activated by α-GalCer were shown to promote the expansion and suppressive activity of regulatory T (Treg) cells to prevent myasthenia gravis in mice. 8 Ronet et al. 9 reported that the activation of iNKT cells by the administration of α-GalCer prior to
Toxoplasma gondii infection can augment the frequency of IL-10-secreting Treg cells to reduce inflammation in ileitis. These findings highlight that iNKT cells have the ability to induce Treg cells, which result in peripheral tolerance. However, much less is known whether α-GalCer can induce the generation of lung Treg cells through the activation of iNKT cells to promote airway tolerance.
Airway exposure to potential environment allergens can lead to immunological tolerance, and Treg cells play a crucial role in the development of the airway homeostatic state and limiting airway inflammation related to allergic asthma. 10, 11 In our previous study, we found that intraperitoneal administration of α-GalCer had the ability to stimulate iNKT cells, but α-GalCer-activated iNKT cells do not elicit airway inflammation in wild-type (WT) mice in the absence of ovalbumin (OVA) immunization and challenge. 12 At present, it is
proposed that iNKT cells have the capacity to induce Treg cells, which give rise to peripheral tolerance. 8, 9 Thus, it was hypothesized that intraperitoneal administration of α-GalCer may induce the generation of lung Treg cells through the activation of iNKT cells in naive mice.
To verify this hypothesis, we have investigated the expansion and suppressive activity of lung Treg cells using iNKT cell-knockout mice and co-culture experiments in vitro. We also compared airway inflammation and airway hyperresponsiveness (AHR) after α-GalCer administration in specific anti-CD25 mAb-treated mice. Our data demonstrate that intraperitoneal administration of α-GalCer can induce the generation of lung Treg cells in mice through the release of IL-2 by the activated iNKT cells.
| MATERIALS AND METHODS

| Mice
Wild-type BALB/c mice, 6-8 week old, were purchased from the Center of Animal Experiment of Wuhan University (Wuhan, China).
CD1d-knockout mice on BALB/c background were obtained from
The Jackson Laboratory (Bar Harbor, ME). All mice were female and maintained under environmentally controlled and specific pathogenfree conditions (22°C, 12 hours light/12 hours dark cycle) at the animal Biosafety Level three Laboratory of the Center of Animal Experiment of Wuhan University (Wuhan, China). All animal care and handling procedures were in accordance with the Institutional Ethics
Committee of Wuhan University.
| In vivo administration of α-GalCer
A stock solution of α-GalCer (KNR7000) (Enzo Life Sciences, Ann
Arbor, MI) was diluted into 0.01 mg/mL in 0.5% polysorbate-20 and stored at −20°C for further study. The intraperitoneal injection was used as the route of administration of α-GalCer, as previously reported. 13 In some experiments, intravenous administration of α-GalCer was served as control. Mice were intraperitoneally administrated or intravenously injected via tail vein with 2 μg of α-GalCer.
Control mice were intraperitoneally injected with the same amount of 0.5% polysorbate-20 in PBS alone.
| Airway tolerance and Th2 inflammatory responses
The protocol was performed according to the report as previously described. 14 
| In vivo Ab administration
For selective depletion of CD25 + T cells, 500 μg of anti-CD25 mAb (clone PC61; BD Pharmingen, San Diego, CA) or IgG isotype mAb was intravenously administrated into mice. A total of 150 μg of anti-IL-2 mAb (IgG2a, clone S4B6; BD Pharmingen) or IgG isotype mAb was intravenously administrated into mice for initial neutralization of IL-2. After resting for 72 hours, the mice were intraperitoneally injected with α-GalCer or PBS. Three days later, mice were killed for further study.
were cultured together with α-GalCer (100 ng/mL) in round-bottom 96-well plates pre-bound with anti-CD3 (2 μg/mL) and anti-CD28 To isolate lung iNKT cells, the lungs from WT mice intraperitoneally treated with α-GalCer were removed, cut into small pieces, digested with collagenase I (1 mg/mL, Invitrogen, CA) at 37°C for 1 hour and filtered via a 100-μm nylon net filter. The lung MNCs were sorted by centrifugation at 800 × g for 20 minutes at room temperature in a Lymphoprep gradient (density = 1.081 mg/mL; TBD, Tianjin, China).
Invariant natural killer T cells were sorted using magnetic bead purification following the manufacturer's instruments (Miltenyi Biotec). 
| Flow cytometric analysis
The MNCs from lungs were obtained and resuspended in the fluo- 
| Measurement of airway hyperresponsiveness
Mice were anesthetized and inserted with a 20-gauge polyethylene catheter, and subsequently mechanical ventilation was performed.
Dynamic compliance (Cdyn) and airway resistance (RL) to increasing dosages of aerosolized methacholine (Mch), ranging from 3.12 to 50 mg/mL in PBS, for 3 minutes were determined by the FinePointe RC system (Wilmington, NC) to analyse AHR. Non-specific airway responsiveness was measured through exposing mice to aerosolized PBS to decide the baseline value.
| Bronchoalveolar lavage and lung histologic analysis
Mice were euthanized and lungs were lavaged by a catheter with a total volume of 1.5 mL PBS containing 1 mmol/L sodium EDTA, which was followed by lung resection, as previously described. 12 The levels of IL-2, IL-4, IL-5, IL-10, IL-13 and IFN-γ in the supernatants were assessed by ELISA according to the manufacturer's instructions (eBioscience). Cells recovered from the BALF were collected and stained with May-Grunwald Giemsa (Jiancheng, Nanjing, China) for differential cell counting.
The right lungs were excised after bronchoalveolar lavage (BAL) and immediately fixed in 4% buffered paraformaldehyde. Subsequently, the samples were dehydrated and embedded in paraffin.
Lung tissue sections were stained using haematoxylin-eosin (HE) staining to evaluate perivascular and peribronchial inflammation and periodic acid-Schiff (PAS) staining (Baso, Taiwan, China) to assess goblet cell hyperplasia.
| Statistical analyses
All data are expressed as the mean ± SD. Statistical analyses were performed with a student's unpaired t test or one-way ANOVA using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA) software.
P < 0.05 was considered statistically significant. shown as mean ± SD of three independent experiments (n = 18), and one representative experiment is indicated. *P < 0.05; **P < 0.01. NS, not significant CHEN ET AL.
| 1077 the supernatants were collected to measure the concentration of IL-10 by ELISA. We observed that IL-10 production in the supernatants from WT mice treated with α-GalCer was not markedly elevated, compared with WT mice treated with PBS ( Figure 3A ) (P > 0.05), and IL-10 production in the supernatants was similar between CD1d-knockout mice treated with α-GalCer and PBS ( Figure 3A) (P > 0.05). Surprisingly, there was no significant difference in the concentration of IL-10 in the supernatants between WT mice and CD1d-knockout mice treated with α-GalCer ( Figure 3A ) (P > 0.05).
To (also called Traj18), which is needed for iNKT-TCR formation. 25 Therefore, Traj18 −/− mice are solely devoid of iNKT cells (also called type I NKT cells). However, the diversity of the overall TCR repertoire is impaired in Traj18 −/− mice, leading to an almost 60% reduction in the TCRα repertoire diversity. 26 It is likely that the lower diversity of overall αβ TCR from the original Traj18 −/− mice contribute to the divergent results that have been addressed by some of the studies that utilized the mice. 27 Another model utilizes mice deficient in CD1d, which is necessary for NKT cell development. [28] [29] [30] 
| 1083
In this study, the intraperitoneal injection was used as the route of administration of α-GalCer, as previously reported, 13 to investi- can be performed before allergen sensitization has occurred. 42 As such, further study in this area will be required.
